В NHS announced the introduction of artificial intelligence in the UK National Health Service to prescribe medicines for patients with colon cancer. The technology allows for a more precise selection of medicines, increasing the effectiveness of treatment.
Implementing AI in the NHS
The NHS has officially announced the use of artificial intelligence to determine the most effective medicines for patients with colon cancer. The system analyses the individual characteristics of the disease and helps doctors make decisions about therapy.
According to NHS representatives, the technology has already been implemented in several clinics and shows encouraging results. The use of AI avoids the prescription of ineffective drugs and improves the prognosis for patients.
Benefits for patients
Patients treated with AI receive individualised medication recommendations. This increases the chances of successful treatment and reduces side effects.
Doctors note that the new approach significantly reduces the time required to select therapy. Patients report an improvement in their quality of life during treatment.
Reaction of the medical community
The UK medical community positively assesses introduction of innovations. Experts emphasise the importance of precise drug selection for patients with cancer.
At the same time, some experts call for caution and further research into the technology's effectiveness in the long term.
Future plans
The NHS plans to expand the use of the AI system to other types of cancer. According to the developers, the technology has the potential to change approaches to cancer treatment in the future.







